Merck
CN

Recoded organisms engineered to depend on synthetic amino acids.

Nature (2015-01-22)
Alexis J Rovner, Adrian D Haimovich, Spencer R Katz, Zhe Li, Michael W Grome, Brandon M Gassaway, Miriam Amiram, Jaymin R Patel, Ryan R Gallagher, Jesse Rinehart, Farren J Isaacs
ABSTRACT

Genetically modified organisms (GMOs) are increasingly used in research and industrial systems to produce high-value pharmaceuticals, fuels and chemicals. Genetic isolation and intrinsic biocontainment would provide essential biosafety measures to secure these closed systems and enable safe applications of GMOs in open systems, which include bioremediation and probiotics. Although safeguards have been designed to control cell growth by essential gene regulation, inducible toxin switches and engineered auxotrophies, these approaches are compromised by cross-feeding of essential metabolites, leaked expression of essential genes, or genetic mutations. Here we describe the construction of a series of genomically recoded organisms (GROs) whose growth is restricted by the expression of multiple essential genes that depend on exogenously supplied synthetic amino acids (sAAs). We introduced a Methanocaldococcus jannaschii tRNA:aminoacyl-tRNA synthetase pair into the chromosome of a GRO derived from Escherichia coli that lacks all TAG codons and release factor 1, endowing this organism with the orthogonal translational components to convert TAG into a dedicated sense codon for sAAs. Using multiplex automated genome engineering, we introduced in-frame TAG codons into 22 essential genes, linking their expression to the incorporation of synthetic phenylalanine-derived amino acids. Of the 60 sAA-dependent variants isolated, a notable strain harbouring three TAG codons in conserved functional residues of MurG, DnaA and SerS and containing targeted tRNA deletions maintained robust growth and exhibited undetectable escape frequencies upon culturing ∼10(11) cells on solid media for 7 days or in liquid media for 20 days. This is a significant improvement over existing biocontainment approaches. We constructed synthetic auxotrophs dependent on sAAs that were not rescued by cross-feeding in environmental growth assays. These auxotrophic GROs possess alternative genetic codes that impart genetic isolation by impeding horizontal gene transfer and now depend on the use of synthetic biochemical building blocks, advancing orthogonal barriers between engineered organisms and the environment.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ribonucleic acid, transfer from bovine liver, Type XI, lyophilized powder
Sigma-Aldrich
Ribonucleic acid, transfer from wheat germ, Type V, 15-19 units/mg solid
Sigma-Aldrich
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae), buffered aqueous solution
Sigma-Aldrich
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae), Type X-SA, lyophilized powder
Sigma-Aldrich
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae), buffered aqueous solution
Supelco
L-Phenylalanine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
L-Phenylalanine, 99%, FCC
Phenylalanine, European Pharmacopoeia (EP) Reference Standard
Supelco
L-Phenylalanine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Phenylalanine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
USP
L-Phenylalanine, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Ribonucleic acid, transfer from Escherichia coli, Type XX, Strain W, lyophilized powder
Sigma-Aldrich
L-Phenylalanine, reagent grade, ≥98%
Sigma-Aldrich
L-Phenylalanine, BioUltra, ≥99.0% (NT)